PROCEPT BioRobotics Corporation
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinaā¦ read more
Healthcare
Medical Devices
2 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$40.71
Price-2.12%
-$0.88
1Y
Price
Market Cap
$2.265b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-59.4%
EBITDA Margin-58.3%
Net Profit Margin-76.9%
Free Cash Flow MarginRevenue
$274.950m
+14.8%
1y CAGR+71.3%
3y CAGR+140.2%
5y CAGREarnings
-$84.145m
+2.4%
1y CAGR-20.3%
3y CAGR-17.0%
5y CAGREPS
-$0.75
+5.4%
1y CAGR-16.1%
3y CAGR-13.6%
5y CAGRBook Value
$385.796m
$513.054m
Assets-
Liabilities$79.367m
DebtDebt to Assets
15.5%
-0.8x
Debt to EBITDAFree Cash Flow
-$88.206m
+5.3%
1y CAGR-32.8%
3y CAGR-29.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company